DNTH vs QRVO · rev $17.8M vs P/E 27, rev $3.68B
Dianthus Therapeutics Inc. (DNTH) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
DNTH currently screens at market cap $4.40B. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the DNTH and QRVO stock pages for the full models.
Not investment advice.